SCHEMBL5998932

SCHEMBL5998932

O=C1Cc2cc([N+](=O)[O-])ccc2N1CCF

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.51
GAA P10253 2/20 0.51
MEN1 O00255 2/20 0.51
GRIN1 Q05586 1/20 0.44
GRIN2B Q13224 1/20 0.44
ALDH1A1 P00352 4/20 0.41
CASP6 P55212 3/20 0.41
POLB P06746 1/20 0.41
APEX1 P27695 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 2/20 0.41
CASP1 P29466 2/20 0.40
CASP3 P42574 2/20 0.40
CASP4 P49662 2/20 0.40
CASP7 P55210 2/20 0.40
CASP9 P55211 2/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
TDP2 O95551 1/20 0.40
ADRA2A P08913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5505203 0.94 GRIN1 (0.50) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL5121854 0.86 GAA (0.51) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL4106672 0.83 GAA (0.53) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL26621565 0.83 GAA (0.48) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL16370713 0.83 GAA (0.48) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL30672820 0.83 GAA (0.48) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL26621639 0.81 POLB (0.48) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL5999587 0.80 GAA (0.50) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL5113994 0.80 KMT2A (0.50) KMT2AGAAMEN1GRIN1GRIN2B
SCHEMBL11616274 0.78 CASP1 (0.60) KMT2AGAAMEN1GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060030609-A1 Oxazolidinones containing oxindoles as antibacterial agents LUEHR GARY W 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030609-A1 Oxazolidinones containing oxindoles as antibacterial agents OXA1L, OXSR1, OXER1 KMT2A 3894/4885GAA 4408/4885MEN1 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.